Breast Cancer
Screening and referral pathways for breast cancer.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
ESMO: Breast Cancer
National
European Commission: European guidelines on breast cancer screening and diagnosisNational
NICE CKS: Breast cancer - managing FHNational
NICE CKS: Breast cancer - recognition and referralNational
NICE guideline [CG164]: Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancerNational
NICE guideline [NG101]: Early and locally advanced breast cancer: diagnosis and managementNational
SIGN 134: Treatment of primary breast cancerNational
ACOG Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk WomenLocal
ACP Guidance Statement: Screening for Breast Cancer in Average-Risk WomenLocal
American Cancer Society Breast Cancer Screening GuidelinesLocal
American Society of Breast Surgeons (ASBrS) Clinical Consensus Statements: Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema (Part 1)Local
ASCO Clinical Practice Guidelines: Breast CancerLocal
ASTRO Clinical Practice Guideline: Partial Breast Irradiation for Patients with Early-Stage Invasive Breast Cancer or Ductal Carcinoma In SituLocal
CAP Guideline: Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast CancerLocal
ESMO Clinical Practice Guidelines: Early and Metastatic Breast CancerLocal
NCCN Clinical Practice Guidelines in Oncology: Breast CancerLocal
NCI Breast Cancer Treatment (PDQ®)–Health Professional VersionLocal
NICE guideline [CG101]: Early and locally advanced breast cancer: diagnosis and managementLocal
Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Breast CancerLocal
US Preventive Services Task Force Recommendation Statement: Breast Cancer ScreeningLocal